Story thread · 3 reports / 2 sources

Viomi Technology regains compliance with Nasdaq minimum bid price rule

seekingalpha.com · 14h · first report

The coverage

  1. Moleculin Biotech receives Nasdaq delisting notice after minimum bid price violation

    investing.com · 3h

The conversation · 0

Sign in to join the conversation.

No comments yet — start the thread.